Literature DB >> 29628497

Activated pancreatic stellate cells inhibit NK cell function in the human pancreatic cancer microenvironment.

Qiang Huang1, Mei Huang2, Futao Meng2, Rui Sun3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29628497      PMCID： PMC6318268          DOI： 10.1038/s41423-018-0014-2

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  12 in total

Review 1.  Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend?

Authors:  Hyon-Seung Yi; Won-Il Jeong
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

2.  Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.

Authors:  Zhongming Tan; Qianghui Liu; Runqiu Jiang; Long Lv; Siamak S Shoto; Isabelle Maillet; Valerie Quesniaux; Junwei Tang; Wenjie Zhang; Beicheng Sun; Bernhard Ryffel
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

Review 3.  Roles of estrogens on myeloid-derived suppressor cells in cancer and autoimmune diseases.

Authors:  Jing Ren; Yayi Hou; Tingting Wang
Journal:  Cell Mol Immunol       Date:  2017-12-25       Impact factor: 11.530

4.  Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment.

Authors:  Thomas A Mace; Mark Bloomston; Gregory B Lesinski
Journal:  Oncoimmunology       Date:  2013-05-07       Impact factor: 8.110

5.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

6.  Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes.

Authors:  Rifaat Safadi; Masayuki Ohta; Carlos E Alvarez; M Isabel Fiel; Meena Bansal; Wajahat Z Mehal; Scott L Friedman
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

7.  Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells.

Authors:  M V Apte; S Park; P A Phillips; N Santucci; D Goldstein; R K Kumar; G A Ramm; M Buchler; H Friess; J A McCarroll; G Keogh; N Merrett; R Pirola; J S Wilson
Journal:  Pancreas       Date:  2004-10       Impact factor: 3.327

Review 8.  A look at the progress of treating pancreatic cancer over the past 20 years.

Authors:  Ruediger Goess; Helmut Friess
Journal:  Expert Rev Anticancer Ther       Date:  2018-01-16       Impact factor: 4.512

9.  Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.

Authors:  Ursula Manuelpillai; Dinushka Lourensz; Vijesh Vaghjiani; Jorge Tchongue; Derek Lacey; Jing-Yang Tee; Padma Murthi; James Chan; Alexander Hodge; William Sievert
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

10.  Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.

Authors:  Abasi Ene-Obong; Andrew J Clear; Jennifer Watt; Jun Wang; Rewas Fatah; John C Riches; John F Marshall; Joanne Chin-Aleong; Claude Chelala; John G Gribben; Alan G Ramsay; Hemant M Kocher
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682
View more
  13 in total

Review 1.  Advances in NK cell production.

Authors:  Fang Fang; Siqi Xie; Minhua Chen; Yutong Li; Jingjing Yue; Jie Ma; Xun Shu; Yongge He; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

Review 2.  Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.

Authors:  Wei Mu; Zhe Wang; Margot Zöller
Journal:  Front Oncol       Date:  2019-12-16       Impact factor: 6.244

3.  Technical advances in NK cell-based cellular immunotherapy.

Authors:  Fang Fang; Wei Wang; Minhua Chen; Zhigang Tian; Weihua Xiao
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

Review 4.  Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy.

Authors:  Cai Zhang; Yuxia Liu
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

Review 5.  Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma.

Authors:  Zoe X Malchiodi; Louis M Weiner
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

Review 6.  B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments.

Authors:  Yuan Wei; Chun-Xiang Huang; Xiao Xiao; Dong-Ping Chen; Hong Shan; Huanhuan He; Dong-Ming Kuang
Journal:  Oncogene       Date:  2021-06-29       Impact factor: 9.867

Review 7.  Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy.

Authors:  Cai Zhang; Yuan Hu; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2021-07-15       Impact factor: 22.096

Review 8.  Molecular Regulation of NK Cell Maturation.

Authors:  Jiacheng Bi; Xuefu Wang
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

Review 9.  Metabolism of Natural Killer Cells and Other Innate Lymphoid Cells.

Authors:  Jingjing Cong
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

Review 10.  The Immune Microenvironment in Pancreatic Cancer.

Authors:  Magdalena Huber; Corinna U Brehm; Thomas M Gress; Malte Buchholz; Bilal Alashkar Alhamwe; Elke Pogge von Strandmann; Emily P Slater; Jörg W Bartsch; Christian Bauer; Matthias Lauth
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.